董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Shuang Wu | 男 | Chief Executive Officer, Director and Chairman of the Board | 44 | 未披露 | 未持股 | 2026-03-23 |
| Baiming Yu | 男 | Chief Operating Officer and Director | 56 | 未披露 | 10.06 | 2026-03-23 |
| Robert Johnson | 男 | Independent Director | 49 | 未披露 | 未持股 | 2026-03-23 |
| Zhenguo Wu | 男 | Independent Director | 40 | 未披露 | 未持股 | 2026-03-23 |
| Qisheng Lin | 男 | Independent Director | -- | 未披露 | 未持股 | 2026-03-23 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Shuang Wu | 男 | Chief Executive Officer, Director and Chairman of the Board | 44 | 未披露 | 未持股 | 2026-03-23 |
| Ningfang Liang | 男 | Chief Financial Officer | 54 | 未披露 | 未持股 | 2026-03-23 |
| Baiming Yu | 男 | Chief Operating Officer and Director | 56 | 未披露 | 10.06 | 2026-03-23 |
董事简历
中英对照 | 中文 | 英文- Shuang Wu
-
Shuang Wu，拥有丰富的管理和财务经验。在加入Work Medical Technology Group Ltd公司之前，2019年8月至2022年5月，他担任EZGO Technologies Ltd（纳斯达克：EZGO）的首席运营官，EZGO Technologies Ltd专注于锂电池和电动自行车的销售，负责制定和执行业务计划。2018年1月至2019年7月，任常州恒茂电力科技有限公司副总裁，从事业务经营管理工作。2015年6月至2017年12月任上海大丰投资集团有限公司投资总经理。2011年11月至2014年12月，任外汇服务商奥克兰机场Travelex总经理助理。2009年6月至2011年11月任西太平洋银行财务顾问。Wu先生获得梅西大学金融学学士学位和商学硕士学位。
Shuang Wu has served as a director since March 2022, Chief Executive Officer ("CEO") since Augt 2022, and Chairman of the Board of Directors since January 9, 2025. Mr. Wu has extensive managerial and financial experience. Before joining Company, from Augt 2019 to May 2022, he was the Chief Operating Officer of EZGO Technologies Ltd (Nasdaq: EZGO), a company focing on sales of lithium battery and electric bicycle, and was responsible for making and enforcing biness plans. From January 2018 to July 2019, he served as the vice president of Changzhou Hengmao Electricity Technology Co., Ltd., working for biness operation and management. He was the General Manager of Investment of Shanghai Dafeng Investment Group Co., Ltd. from June 2015 to December 2017. From November 2011 to December 2014, he served as the assistant of General Manager of Travelex of Auckland Airport, a foreign exchange service provider. From June 2009 to November 2011, he was a financial adviser of stpac Bank. Mr. Wu received his bachelor's degree of finance and master's degree of biness from Massey University. - Shuang Wu，拥有丰富的管理和财务经验。在加入Work Medical Technology Group Ltd公司之前，2019年8月至2022年5月，他担任EZGO Technologies Ltd（纳斯达克：EZGO）的首席运营官，EZGO Technologies Ltd专注于锂电池和电动自行车的销售，负责制定和执行业务计划。2018年1月至2019年7月，任常州恒茂电力科技有限公司副总裁，从事业务经营管理工作。2015年6月至2017年12月任上海大丰投资集团有限公司投资总经理。2011年11月至2014年12月，任外汇服务商奥克兰机场Travelex总经理助理。2009年6月至2011年11月任西太平洋银行财务顾问。Wu先生获得梅西大学金融学学士学位和商学硕士学位。
- Shuang Wu has served as a director since March 2022, Chief Executive Officer ("CEO") since Augt 2022, and Chairman of the Board of Directors since January 9, 2025. Mr. Wu has extensive managerial and financial experience. Before joining Company, from Augt 2019 to May 2022, he was the Chief Operating Officer of EZGO Technologies Ltd (Nasdaq: EZGO), a company focing on sales of lithium battery and electric bicycle, and was responsible for making and enforcing biness plans. From January 2018 to July 2019, he served as the vice president of Changzhou Hengmao Electricity Technology Co., Ltd., working for biness operation and management. He was the General Manager of Investment of Shanghai Dafeng Investment Group Co., Ltd. from June 2015 to December 2017. From November 2011 to December 2014, he served as the assistant of General Manager of Travelex of Auckland Airport, a foreign exchange service provider. From June 2009 to November 2011, he was a financial adviser of stpac Bank. Mr. Wu received his bachelor's degree of finance and master's degree of biness from Massey University.
- Baiming Yu
-
Baiming Yu，自2022年6月起担任Work Medical Technology Group Ltd首席运营官，担任Work Medical Technology Group Ltd董事。他是杭州Shanyou的创始人，自2002年1月起担任总经理，负责公司的日常运营和管理。此外，他于2012年1月至2018年12月担任Hangzhou Yuanqi Biotech Co., Ltd.总经理。1993年8月至2001年12月任萧山市第一人民医院医生。他在原浙江医科大学获得麻醉医学学士学位，该大学于1998年并入浙江大学。
Baiming Yu has served as Chief Operating Officer ("COO") since August 2022 and he has served as director since August 2024. Mr. Yu has enriched experience in the field of medicine. He is the founder of Hangzhou Shanyou and has been its General Manager since January 2002, responsible for the company's daily operations and management. Additionally, he served as the General Manager of Hangzhou Yuanqi Biotech Co., Ltd. from January 2012 to December 2018. From August 1993 to December 2001, he was a doctor of The First People's Hospital of Xiaoshan City. Mr. Yu received his bachelor's degree of medicine in anesthesia from the former Zhejiang Medical University, which was merged into Zhejiang University in 1998. - Baiming Yu，自2022年6月起担任Work Medical Technology Group Ltd首席运营官，担任Work Medical Technology Group Ltd董事。他是杭州Shanyou的创始人，自2002年1月起担任总经理，负责公司的日常运营和管理。此外，他于2012年1月至2018年12月担任Hangzhou Yuanqi Biotech Co., Ltd.总经理。1993年8月至2001年12月任萧山市第一人民医院医生。他在原浙江医科大学获得麻醉医学学士学位，该大学于1998年并入浙江大学。
- Baiming Yu has served as Chief Operating Officer ("COO") since August 2022 and he has served as director since August 2024. Mr. Yu has enriched experience in the field of medicine. He is the founder of Hangzhou Shanyou and has been its General Manager since January 2002, responsible for the company's daily operations and management. Additionally, he served as the General Manager of Hangzhou Yuanqi Biotech Co., Ltd. from January 2012 to December 2018. From August 1993 to December 2001, he was a doctor of The First People's Hospital of Xiaoshan City. Mr. Yu received his bachelor's degree of medicine in anesthesia from the former Zhejiang Medical University, which was merged into Zhejiang University in 1998.
- Robert Johnson
-
Robert Johnson，自2024年8月起担任WORK Medical董事。他在税务和金融方面拥有超过15年的经验。自2020年2月起，他一直担任BAS Holdings Investments, LLC的财务总监，主要负责定期账户和公司间对账和财务报表报告的审查，以及运营公司的现金、应收账款和应付账款管理。从2017年1月到2020年1月，他担任Lionstone Development, LLC家族办公室的财务总监。从2010年6月到2015年6月，他担任BSL Capital, Inc.家族办公室的财务总监。2005年9月至2010年6月，他担任CBIZ MHM, LLC的高级税务会计师；2004年1月至2005年9月，他担任Mallah Furman and Company的税务会计师。他持有中佛罗里达大学的会计和金融学士学位，以及迈阿密大学的工商管理硕士学位。他是注册管理会计师和注册会计师。
Robert Johnson has served as director since Augt 2024. Mr. Johnson has over 15 years of experience in tax and finance. He has been the Financial Controller of BAS Holdings Investments, LLC since February 2020, primarily responsible for review of periodic account and intercompany reconciliations and financial statement reporting and cash, receivables, and payables management for operating companies. From January 2017 to January 2020, he was the controller for family office of Lionstone Development, LLC. From June 2010 to June 2015, he was the controller for family office of BSL Capital, Inc. From September 2005 to June 2010, he served as a senior tax accountant of CBIZ MHM, LLC, and from January 2004 to September 2005, he was a tax accountant of Mallah Furman and Company. Mr. Johnson received his bachelor's degrees of science in accounting and finance from University of Central Florida, and his MBA degree from University of Miami. He is both a Certified Management Accountant and Certified Public Accountant. - Robert Johnson，自2024年8月起担任WORK Medical董事。他在税务和金融方面拥有超过15年的经验。自2020年2月起，他一直担任BAS Holdings Investments, LLC的财务总监，主要负责定期账户和公司间对账和财务报表报告的审查，以及运营公司的现金、应收账款和应付账款管理。从2017年1月到2020年1月，他担任Lionstone Development, LLC家族办公室的财务总监。从2010年6月到2015年6月，他担任BSL Capital, Inc.家族办公室的财务总监。2005年9月至2010年6月，他担任CBIZ MHM, LLC的高级税务会计师；2004年1月至2005年9月，他担任Mallah Furman and Company的税务会计师。他持有中佛罗里达大学的会计和金融学士学位，以及迈阿密大学的工商管理硕士学位。他是注册管理会计师和注册会计师。
- Robert Johnson has served as director since Augt 2024. Mr. Johnson has over 15 years of experience in tax and finance. He has been the Financial Controller of BAS Holdings Investments, LLC since February 2020, primarily responsible for review of periodic account and intercompany reconciliations and financial statement reporting and cash, receivables, and payables management for operating companies. From January 2017 to January 2020, he was the controller for family office of Lionstone Development, LLC. From June 2010 to June 2015, he was the controller for family office of BSL Capital, Inc. From September 2005 to June 2010, he served as a senior tax accountant of CBIZ MHM, LLC, and from January 2004 to September 2005, he was a tax accountant of Mallah Furman and Company. Mr. Johnson received his bachelor's degrees of science in accounting and finance from University of Central Florida, and his MBA degree from University of Miami. He is both a Certified Management Accountant and Certified Public Accountant.
- Zhenguo Wu
-
Zhenguo Wu，有法律从业经验。他自2024年12月起担任Watson & Band律师事务所的律师。从2021年4月到2024年11月，他担任旭航控股有限公司的董事会秘书兼总法律顾问。从2015年10月到2021年2月，他担任申万宏源证券承销和赞助有限公司投资银行部高级副总裁。他于2010年获得唐山师范大学英语学士学位，并于2013年获得华东政法大学法学硕士学位。
Zhenguo Wu has served as an Independent Director at WORK Medical Technology Group Ltd. (Nasdaq: WOK) since January 2025. In April 2025, he co founded Hubei Kunpeng Zhixing Technology Co., Ltd., where he currently holds the positions of Vice President, Chief Financial Officer, and Board Secretary. Beten January 2025 and April 2025, Mr. Wu also served as Board Secretary at Qingdao Hongri Automotive Technology Co., Ltd., overseeing the company's Nasdaq listing. In December 2024, Mr. Wu joined Watson & Band Law Offices as a lawyer specializing in capital markets legal advisory. From April 2021 to November 2024, he was Board Secretary and General Counsel at Xuhang Holdings Ltd. Prior to that, from October 2015 to February 2021, he was a Senior Vice President in the Investment Banking Division at Shenwan Hongyuan Securities Underwriting and Sponsoring Co., Ltd. From November 2012 to October 2015, he worked at JunZeJun (Shanghai) Law Offices, where he specialized as a lawyer in the Capital Markets Department. Mr. Wu obtained a Master's degree in law from East China University of Political Science and Law in 2013 and a Bachelor's degree in English from Tangshan Normal University in 2010. - Zhenguo Wu，有法律从业经验。他自2024年12月起担任Watson & Band律师事务所的律师。从2021年4月到2024年11月，他担任旭航控股有限公司的董事会秘书兼总法律顾问。从2015年10月到2021年2月，他担任申万宏源证券承销和赞助有限公司投资银行部高级副总裁。他于2010年获得唐山师范大学英语学士学位，并于2013年获得华东政法大学法学硕士学位。
- Zhenguo Wu has served as an Independent Director at WORK Medical Technology Group Ltd. (Nasdaq: WOK) since January 2025. In April 2025, he co founded Hubei Kunpeng Zhixing Technology Co., Ltd., where he currently holds the positions of Vice President, Chief Financial Officer, and Board Secretary. Beten January 2025 and April 2025, Mr. Wu also served as Board Secretary at Qingdao Hongri Automotive Technology Co., Ltd., overseeing the company's Nasdaq listing. In December 2024, Mr. Wu joined Watson & Band Law Offices as a lawyer specializing in capital markets legal advisory. From April 2021 to November 2024, he was Board Secretary and General Counsel at Xuhang Holdings Ltd. Prior to that, from October 2015 to February 2021, he was a Senior Vice President in the Investment Banking Division at Shenwan Hongyuan Securities Underwriting and Sponsoring Co., Ltd. From November 2012 to October 2015, he worked at JunZeJun (Shanghai) Law Offices, where he specialized as a lawyer in the Capital Markets Department. Mr. Wu obtained a Master's degree in law from East China University of Political Science and Law in 2013 and a Bachelor's degree in English from Tangshan Normal University in 2010.
- Qisheng Lin
-
林奇生，拥有丰富的医学和学术研究经验。2025年1月起任上海交通大学医学院仁济医院肾脏科副教授，2024年7月起任同科研究员。2019年10月至2021年1月，他在纽约西奈山伊坎医学院担任副研究员。2021年7月-2024年6月完成仁济医院内科住院医师实习。林博士于2021年6月获得上海交通大学医学院医学博士学位。
Qisheng Lin,has extensive experience in medicine and academic research. He has served as an Associate Professor in the Department of Nephrology at Renji Hospital, Shanghai Jiao Tong University School of Medicine, since January 2025, and as a Fellow in the same department since July 2024. He worked as an Associate Researcher at the Icahn School of Medicine at Mount Sinai in New York from October 2019 to January 2021. From July 2021 to June 2024, he completed his residency in the Department of Internal Medicine at Renji Hospital. Dr. Lin obtained his Ph.D. in Medicine from Shanghai Jiao Tong University School of Medicine in June 2021. - 林奇生，拥有丰富的医学和学术研究经验。2025年1月起任上海交通大学医学院仁济医院肾脏科副教授，2024年7月起任同科研究员。2019年10月至2021年1月，他在纽约西奈山伊坎医学院担任副研究员。2021年7月-2024年6月完成仁济医院内科住院医师实习。林博士于2021年6月获得上海交通大学医学院医学博士学位。
- Qisheng Lin,has extensive experience in medicine and academic research. He has served as an Associate Professor in the Department of Nephrology at Renji Hospital, Shanghai Jiao Tong University School of Medicine, since January 2025, and as a Fellow in the same department since July 2024. He worked as an Associate Researcher at the Icahn School of Medicine at Mount Sinai in New York from October 2019 to January 2021. From July 2021 to June 2024, he completed his residency in the Department of Internal Medicine at Renji Hospital. Dr. Lin obtained his Ph.D. in Medicine from Shanghai Jiao Tong University School of Medicine in June 2021.
高管简历
中英对照 | 中文 | 英文- Shuang Wu
Shuang Wu，拥有丰富的管理和财务经验。在加入Work Medical Technology Group Ltd公司之前，2019年8月至2022年5月，他担任EZGO Technologies Ltd（纳斯达克：EZGO）的首席运营官，EZGO Technologies Ltd专注于锂电池和电动自行车的销售，负责制定和执行业务计划。2018年1月至2019年7月，任常州恒茂电力科技有限公司副总裁，从事业务经营管理工作。2015年6月至2017年12月任上海大丰投资集团有限公司投资总经理。2011年11月至2014年12月，任外汇服务商奥克兰机场Travelex总经理助理。2009年6月至2011年11月任西太平洋银行财务顾问。Wu先生获得梅西大学金融学学士学位和商学硕士学位。
Shuang Wu has served as a director since March 2022, Chief Executive Officer ("CEO") since Augt 2022, and Chairman of the Board of Directors since January 9, 2025. Mr. Wu has extensive managerial and financial experience. Before joining Company, from Augt 2019 to May 2022, he was the Chief Operating Officer of EZGO Technologies Ltd (Nasdaq: EZGO), a company focing on sales of lithium battery and electric bicycle, and was responsible for making and enforcing biness plans. From January 2018 to July 2019, he served as the vice president of Changzhou Hengmao Electricity Technology Co., Ltd., working for biness operation and management. He was the General Manager of Investment of Shanghai Dafeng Investment Group Co., Ltd. from June 2015 to December 2017. From November 2011 to December 2014, he served as the assistant of General Manager of Travelex of Auckland Airport, a foreign exchange service provider. From June 2009 to November 2011, he was a financial adviser of stpac Bank. Mr. Wu received his bachelor's degree of finance and master's degree of biness from Massey University.- Shuang Wu，拥有丰富的管理和财务经验。在加入Work Medical Technology Group Ltd公司之前，2019年8月至2022年5月，他担任EZGO Technologies Ltd（纳斯达克：EZGO）的首席运营官，EZGO Technologies Ltd专注于锂电池和电动自行车的销售，负责制定和执行业务计划。2018年1月至2019年7月，任常州恒茂电力科技有限公司副总裁，从事业务经营管理工作。2015年6月至2017年12月任上海大丰投资集团有限公司投资总经理。2011年11月至2014年12月，任外汇服务商奥克兰机场Travelex总经理助理。2009年6月至2011年11月任西太平洋银行财务顾问。Wu先生获得梅西大学金融学学士学位和商学硕士学位。
- Shuang Wu has served as a director since March 2022, Chief Executive Officer ("CEO") since Augt 2022, and Chairman of the Board of Directors since January 9, 2025. Mr. Wu has extensive managerial and financial experience. Before joining Company, from Augt 2019 to May 2022, he was the Chief Operating Officer of EZGO Technologies Ltd (Nasdaq: EZGO), a company focing on sales of lithium battery and electric bicycle, and was responsible for making and enforcing biness plans. From January 2018 to July 2019, he served as the vice president of Changzhou Hengmao Electricity Technology Co., Ltd., working for biness operation and management. He was the General Manager of Investment of Shanghai Dafeng Investment Group Co., Ltd. from June 2015 to December 2017. From November 2011 to December 2014, he served as the assistant of General Manager of Travelex of Auckland Airport, a foreign exchange service provider. From June 2009 to November 2011, he was a financial adviser of stpac Bank. Mr. Wu received his bachelor's degree of finance and master's degree of biness from Massey University.
- Ningfang Liang
Ningfang Liang自2022年6月起担任Work Medical Technology Group Ltd的首席财务官。Liang先生在金融领域工作并为在美国上市的公司工作超过15年。从2008年12月到2011年6月，他是曾在纳斯达克上市的Sirius International Insurance Group的经理（纳斯达克代码：SG）。从2016年6月到2022年6月，他重新加入了该公司，并恢复了经理的职位，负责评估业务绩效和合并财务结果，为SEC备案做准备，并从财务角度提出业务计划的建议。从2013年3月至2016年1月，以及从2011年6月至2013年2月，他分别担任了两家美国上市公司的首席财务官，分别是Tantech Holdings Ltd.（纳斯达克代码：TANH）和中国耐高新材料股份有限公司（OTCMKTS代码：CHGS）。从2006年12月到2008年12月，他在美国国际集团公司（NYSE代码：AIG）担任高级会计师。他曾于2005年1月至2006年12月担任曾在纳斯达克上市的Celgene Corporation的财务分析员（纳斯达克代码：CELG）。Liang先生拥有上海财经大学理学学士学位和University of Illinois, Urbana-ChampaignMBA学位，并且是新泽西州和伊利诺伊州的注册会计师。
Ningfang Liang has served as Chief Financial Officer ("CFO") since Augt 2022. Mr. Liang has been in the financial field and working for U.S. listed companies for over 15 years. From December 2008 to June 2011, he was the manager of Siri International Insurance Group, a former Nasdaq listed company (Nasdaq: SG), and from June 2016 to June 2022, he rejoined the company and resumed being the manager, responsible for evaluating biness performance and consolidated financial results, preparing for SEC filings and recommending changes for biness plan from the perspective of finance. From March 2013 to January 2016, and from June 2011 to February 2013, he worked as the Chief Financial Officer of two U.S. public companies respectively, Tantech Holdings Ltd. (Nasdaq: TANH) and China GengSheng Minerals, Inc. (OTCMKTS: CHGS). From December 2006 to December 2008, he worked as a senior accountant in American International Group Inc. (NYSE: AIG). He was a financial analyst of Celgene Corporation, a former Nasdaq listed company (Nasdaq: CELG), from January 2005 to December 2006. Mr. Liang has a bachelor's degree of science from Shanghai University of Finance and Economics and an MBA degree from University of Illinois, Urbana Champaign. He is also a Certified Public Accountant of the states of New Jersey and Illinois.- Ningfang Liang自2022年6月起担任Work Medical Technology Group Ltd的首席财务官。Liang先生在金融领域工作并为在美国上市的公司工作超过15年。从2008年12月到2011年6月，他是曾在纳斯达克上市的Sirius International Insurance Group的经理（纳斯达克代码：SG）。从2016年6月到2022年6月，他重新加入了该公司，并恢复了经理的职位，负责评估业务绩效和合并财务结果，为SEC备案做准备，并从财务角度提出业务计划的建议。从2013年3月至2016年1月，以及从2011年6月至2013年2月，他分别担任了两家美国上市公司的首席财务官，分别是Tantech Holdings Ltd.（纳斯达克代码：TANH）和中国耐高新材料股份有限公司（OTCMKTS代码：CHGS）。从2006年12月到2008年12月，他在美国国际集团公司（NYSE代码：AIG）担任高级会计师。他曾于2005年1月至2006年12月担任曾在纳斯达克上市的Celgene Corporation的财务分析员（纳斯达克代码：CELG）。Liang先生拥有上海财经大学理学学士学位和University of Illinois, Urbana-ChampaignMBA学位，并且是新泽西州和伊利诺伊州的注册会计师。
- Ningfang Liang has served as Chief Financial Officer ("CFO") since Augt 2022. Mr. Liang has been in the financial field and working for U.S. listed companies for over 15 years. From December 2008 to June 2011, he was the manager of Siri International Insurance Group, a former Nasdaq listed company (Nasdaq: SG), and from June 2016 to June 2022, he rejoined the company and resumed being the manager, responsible for evaluating biness performance and consolidated financial results, preparing for SEC filings and recommending changes for biness plan from the perspective of finance. From March 2013 to January 2016, and from June 2011 to February 2013, he worked as the Chief Financial Officer of two U.S. public companies respectively, Tantech Holdings Ltd. (Nasdaq: TANH) and China GengSheng Minerals, Inc. (OTCMKTS: CHGS). From December 2006 to December 2008, he worked as a senior accountant in American International Group Inc. (NYSE: AIG). He was a financial analyst of Celgene Corporation, a former Nasdaq listed company (Nasdaq: CELG), from January 2005 to December 2006. Mr. Liang has a bachelor's degree of science from Shanghai University of Finance and Economics and an MBA degree from University of Illinois, Urbana Champaign. He is also a Certified Public Accountant of the states of New Jersey and Illinois.
- Baiming Yu
Baiming Yu，自2022年6月起担任Work Medical Technology Group Ltd首席运营官，担任Work Medical Technology Group Ltd董事。他是杭州Shanyou的创始人，自2002年1月起担任总经理，负责公司的日常运营和管理。此外，他于2012年1月至2018年12月担任Hangzhou Yuanqi Biotech Co., Ltd.总经理。1993年8月至2001年12月任萧山市第一人民医院医生。他在原浙江医科大学获得麻醉医学学士学位，该大学于1998年并入浙江大学。
Baiming Yu has served as Chief Operating Officer ("COO") since August 2022 and he has served as director since August 2024. Mr. Yu has enriched experience in the field of medicine. He is the founder of Hangzhou Shanyou and has been its General Manager since January 2002, responsible for the company's daily operations and management. Additionally, he served as the General Manager of Hangzhou Yuanqi Biotech Co., Ltd. from January 2012 to December 2018. From August 1993 to December 2001, he was a doctor of The First People's Hospital of Xiaoshan City. Mr. Yu received his bachelor's degree of medicine in anesthesia from the former Zhejiang Medical University, which was merged into Zhejiang University in 1998.- Baiming Yu，自2022年6月起担任Work Medical Technology Group Ltd首席运营官，担任Work Medical Technology Group Ltd董事。他是杭州Shanyou的创始人，自2002年1月起担任总经理，负责公司的日常运营和管理。此外，他于2012年1月至2018年12月担任Hangzhou Yuanqi Biotech Co., Ltd.总经理。1993年8月至2001年12月任萧山市第一人民医院医生。他在原浙江医科大学获得麻醉医学学士学位，该大学于1998年并入浙江大学。
- Baiming Yu has served as Chief Operating Officer ("COO") since August 2022 and he has served as director since August 2024. Mr. Yu has enriched experience in the field of medicine. He is the founder of Hangzhou Shanyou and has been its General Manager since January 2002, responsible for the company's daily operations and management. Additionally, he served as the General Manager of Hangzhou Yuanqi Biotech Co., Ltd. from January 2012 to December 2018. From August 1993 to December 2001, he was a doctor of The First People's Hospital of Xiaoshan City. Mr. Yu received his bachelor's degree of medicine in anesthesia from the former Zhejiang Medical University, which was merged into Zhejiang University in 1998.